Cathay Biotech (SH:688065) Zheng Quan Zhi Xing·2025-08-01 16:36Core Points - The company, Shanghai Kaisa Biotechnology Co., Ltd., has announced a share repurchase plan proposed by its original controlling shareholder, Cathay Industrial Biotech Ltd. [1] - The repurchase period is set from October 21, 2024, to October 20, 2025, with an expected repurchase amount between 10 million yuan and 20 million yuan [1] - The repurchased shares will be used for employee stock ownership plans or equity incentives [1] Summary of Share Repurchase Details - The total amount for the share repurchase is not less than 10 million yuan and not more than 20 million yuan, with a maximum repurchase price of 67 yuan per share [1] - As of the latest update, the company has repurchased a total of 230,366 shares, which accounts for 0.0319% of the total share capital of 721,289,794 shares [1] - The total amount spent on the repurchase so far is approximately 10,497,716.71 yuan, with the highest purchase price being 53.40 yuan per share and the lowest being 44.08 yuan per share [1][2]